Holen Sie sich die Stockscreener-App
17.17
2.28%
-0.40
Handel nachbörslich:
17.30
0.13
+0.76%
Finanzdaten der Odyssey Therapeutics Inc-Aktie (ODTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 |
| Periodenlänge | 3 Monate | 3 Monate |
| Revenues |
-
|
- |
| Operating Expenses |
39.44%
55.47
|
39.78 |
| Operating Income/Loss |
39.44%
-55.47
|
-39.78 |
| Nonoperating Income/Loss |
69.13%
2.674
|
1.581 |
| Income/Loss From Continuing Operations Before Tax |
38.21%
-52.80
|
-38.20 |
| Income Tax Expense/Benefit |
112.70%
-0.008
|
0.063 |
Net Income/Loss
|
37.96%
-52.79
|
-38.26 |
| Basic Average Shares |
435.34%
30.28
|
5.6557 |
| Diluted Average Shares |
435.34%
30.28
|
5.6557 |
| Basic Earnings Per Share |
74.30%
-1.74
|
-6.77 |
| Diluted Earnings Per Share |
74.30%
-1.74
|
-6.77 |
0.77%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):